CREDIT SUISSE AG/ - HORIZON PHARMA INVT LTD ownership

HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 33 filers reported holding HORIZON PHARMA INVT LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of HORIZON PHARMA INVT LTD
ValueSharesWeighting
Q2 2020$385,000
+67.4%
200,0000.0%0.00%
Q1 2020$230,000
-12.9%
200,0000.0%0.00%
Q4 2019$264,000
+13.3%
200,0000.0%0.00%
Q3 2019$233,000
-57.9%
200,000
-60.0%
0.00%
Q2 2019$554,000
-92.1%
500,000
-91.9%
0.00%
-100.0%
Q1 2019$7,007,000
+1307.0%
6,162,000
+1132.4%
0.01%
+500.0%
Q4 2018$498,000
-1.0%
500,0000.0%0.00%
Q3 2018$503,000
+5.0%
500,0000.0%0.00%
Q2 2018$479,000
+4.4%
500,0000.0%0.00%
Q1 2018$459,000
-67.1%
500,000
-66.7%
0.00%
-100.0%
Q4 2017$1,395,000
-13.2%
1,500,000
-15.7%
0.00%
-50.0%
Q3 2017$1,608,000
+24.4%
1,780,000
+18.7%
0.00%
+100.0%
Q2 2017$1,293,000
+184.2%
1,500,000
+200.0%
0.00%
Q1 2017$455,000
-83.2%
500,000
-82.5%
0.00%
-100.0%
Q4 2016$2,711,000
-34.7%
2,850,000
-33.6%
0.00%
-25.0%
Q3 2016$4,152,000
+14.4%
4,295,000
+7.3%
0.00%0.0%
Q2 2016$3,629,000
+69.9%
4,004,000
+59.7%
0.00%
+33.3%
Q1 2016$2,136,0002,507,0000.00%
Other shareholders
HORIZON PHARMA INVT LTD shareholders Q1 2020
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 99,100,000$94,914,0003.33%
Lion Point Capital, LP 16,000,000$15,312,0001.38%
SYMPHONY ASSET MANAGEMENT LLC 5,000,000$4,804,0000.96%
LINDEN ADVISORS LP 32,106,000$30,888,0000.95%
OAKTREE CAPITAL MANAGEMENT LP 46,262,000$44,449,0000.62%
Nicholas Investment Partners, LP 8,635,000$8,264,0000.58%
ADVENT CAPITAL MANAGEMENT /DE/ 16,785,000$16,100,0000.34%
CANYON CAPITAL ADVISORS LLC 30,000,000$28,712,0000.32%
SSI INVESTMENT MANAGEMENT LLC 3,250,000$3,110,0000.25%
PALISADE CAPITAL MANAGEMENT, LP 6,278,000$6,031,0000.17%
View complete list of HORIZON PHARMA INVT LTD shareholders